Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial

BACKGROUND: The benefits of pharmacotherapy with tiotropium HandiHaler 18 μg for patients with chronic obstructive pulmonary disease (COPD) have been previously demonstrated. However, few data exist regarding the treatment of moderate disease (Global Initiative for Chronic Obstructive Lung Disease (...

Descripción completa

Detalles Bibliográficos
Autores principales: Troosters, Thierry, Sciurba, Frank C, Decramer, Marc, Siafakas, Nikos M, Klioze, Solomon S, Sutradhar, Santosh C, Weisman, Idelle M, Yunis, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373257/
https://www.ncbi.nlm.nih.gov/pubmed/24841833
http://dx.doi.org/10.1038/npjpcrm.2014.3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373257/
https://www.ncbi.nlm.nih.gov/pubmed/24841833
http://dx.doi.org/10.1038/npjpcrm.2014.3

Ejemplares similares